Callan Family Office’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
32,552
+1,330
+4% +$70K 0.02% 533
2026
Q1
$1.92M Buy
31,222
+10,699
+52% +$766K 0.04% 369
2025
Q4
$1.7M Buy
20,523
+15,597
+317% +$1.17M 0.04% 390
2025
Q3
$330K Sell
4,926
-127
-3% -$9.18K 0.01% 671
2025
Q2
$394K Buy
+5,053
New +$387K 0.01% 684

Other funds holding CTSH

Callan Family Office's CTSH Position: Q2 2026 in Review

Callan Family Office increased its Cognizant (CTSH) stake by 4.3% in Q2 2026, buying an estimated $70K and bringing the position to 32,552 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #533.

Callan Family Office first reported a position in CTSH in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.92M in Q1 2026. 918 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.

  • Callan Family Office held 32,552 shares of Cognizant worth $1.26M as of Q2 2026.
  • Callan Family Office bought 1,330 Cognizant shares in Q2 2026, an estimated $70K.
  • Cognizant made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #533 holding.
  • Callan Family Office first reported a position in Cognizant in Q2 2025 and has held it in 5 quarters since.
  • Callan Family Office's Cognizant position peaked at $1.92M in Q1 2026.
  • 918 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.